Arkolith/Insider Trading/SPRY/Form 4

Tanimoto Sarina

CHIEF MEDICAL OFFICER, 10% OwnerARS Pharmaceuticals, Inc. (SPRY) · full profile →Form 4 · filed Aug 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$704K
Net Open-Market Flow
-$704K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 20, 2025Sell(S)38K$14.09$531K1.2M
Aug 19, 2025Sell(S)12K$14.03$173K1.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-022638) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML